IO Biotech, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was USD 26.18 million compared to USD 20.07 million a year ago. Basic loss per share from continuing operations was USD 0.4 compared to USD 0.7 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.5 USD | -2.60% | -3.23% | -20.21% |
26/04 | IO Biotech, Inc. Announces Resignation of Jack Nielsen as Member of the Board of Directors | CI |
15/04 | IO Biotech Announces Marjan Shamsaei as Senior Vice President | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.21% | 101M | |
+22.56% | 46.4B | |
-1.51% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+10.13% | 26.01B | |
-20.44% | 19.52B | |
+26.45% | 12.43B | |
-0.14% | 12.18B | |
-0.47% | 12.13B |
- Stock Market
- Equities
- IOBT Stock
- News IO Biotech, Inc.
- IO Biotech, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023